2025 saw a deliberate inventory normalization in Mexico, leading to lower sales but resilient margins and strong cash flow. Productivity gains and disciplined cost management support a positive 2026 outlook, with gradual top-line recovery and EBITDA margin guidance of 23%-23.5%.
Based on
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.